Literature DB >> 17152065

Neuropathic features in fragile X premutation carriers.

Elizabeth Berry-Kravis1, Christopher G Goetz, Maureen A Leehey, Randi J Hagerman, Lin Zhang, Lexin Li, Danh Nguyen, Deborah A Hall, Nicole Tartaglia, Jennifer Cogswell, Flora Tassone, Paul J Hagerman.   

Abstract

Fragile X-associated tremor/ataxia syndrome (FXTAS) is a progressive neurological condition occurring in fragile X premutation carriers, predominantly males, and resulting in CNS dysfunction including tremor, ataxia, Parkinsonism, and cognitive decline. Neuropathic signs have also been described. The objective of this study was to compare neuropathic signs in fragile X premutation carriers versus controls and determine the relationship of these signs to CGG repeat length and tremor/ataxia. A neuropathy scale was utilized to compare distal tendon reflexes and vibration sense in subjects from a large cohort of carriers and controls undergoing neurological exam and structured videotaping sessions for movement disorder rating. The male carrier group displayed more impairment on total neuropathy, vibration and reflex scores than the corresponding control group, while female carriers were not significantly different from controls. In males, after correction for age effects, there was a correlation between CGG repeat length and both total neuropathy and reflex impairments. Age-adjusted partial correlation analyses showed an association between neuropathy scores and severity of ataxia but not tremor in carrier males and females. These data suggest that neuropathic signs are associated with the fragile X premutation, presumably occurring through the same mechanism proposed for CNS disease, namely, toxicity from expanded-CGG-repeat FMR1 mRNA. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17152065     DOI: 10.1002/ajmg.a.31559

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  55 in total

1.  Immune mediated disorders in women with a fragile X expansion and FXTAS.

Authors:  Isha Jalnapurkar; Nuva Rafika; Flora Tassone; Randi Hagerman
Journal:  Am J Med Genet A       Date:  2014-11-14       Impact factor: 2.802

2.  Sleep apnea in fragile X premutation carriers with and without FXTAS.

Authors:  Alyssa Hamlin; Ying Liu; Danh V Nguyen; Flora Tassone; Lin Zhang; Randi J Hagerman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-09-19       Impact factor: 3.568

3.  New clinical findings in the fragile X-associated tremor ataxia syndrome (FXTAS).

Authors:  Jorge L Juncos; Joash T Lazarus; Emily Graves-Allen; Lisa Shubeck; Michelle Rusin; Gloria Novak; Deborah Hamilton; Julia Rohr; Stephanie L Sherman
Journal:  Neurogenetics       Date:  2011-01-29       Impact factor: 2.660

4.  Fragile X mental retardation protein (FMRP) and the spinal sensory system.

Authors:  Theodore J Price; Ohannes K Melemedjian
Journal:  Results Probl Cell Differ       Date:  2012

5.  Abnormal dendrite and spine morphology in primary visual cortex in the CGG knock-in mouse model of the fragile X premutation.

Authors:  Robert F Berman; Karl D Murray; Gloria Arque; Michael R Hunsaker; H Jürgen Wenzel
Journal:  Epilepsia       Date:  2012-06       Impact factor: 5.864

6.  Late Onset Tremor and Ataxia Syndrome: FXTAS and its Ignored Peripheral Nervous System Findings in Diagnostic Criteria.

Authors:  Amber Eker; Umut Fahrioğlu; Nedime Serakinci
Journal:  Noro Psikiyatr Ars       Date:  2016-03-01       Impact factor: 1.339

7.  Eye movements reveal impaired inhibitory control in adult male fragile X premutation carriers asymptomatic for FXTAS.

Authors:  Ling M Wong; Naomi J Goodrich-Hunsaker; Yingratana McLennan; Flora Tassone; Melody Zhang; Susan M Rivera; Tony J Simon
Journal:  Neuropsychology       Date:  2014-04-28       Impact factor: 3.295

8.  Characterization and Early Detection of Balance Deficits in Fragile X Premutation Carriers With and Without Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS).

Authors:  Joan A O'Keefe; Erin Robertson-Dick; Emily J Dunn; Yan Li; Youping Deng; Amber N Fiutko; Elizabeth Berry-Kravis; Deborah A Hall
Journal:  Cerebellum       Date:  2015-12       Impact factor: 3.847

9.  Expanded clinical phenotype of women with the FMR1 premutation.

Authors:  Sarah M Coffey; Kylee Cook; Nicole Tartaglia; Flora Tassone; Danh V Nguyen; Ruiqin Pan; Hannah E Bronsky; Jennifer Yuhas; Mariya Borodyanskaya; Jim Grigsby; Melanie Doerflinger; Paul J Hagerman; Randi J Hagerman
Journal:  Am J Med Genet A       Date:  2008-04-15       Impact factor: 2.802

10.  Translation of the FMR1 mRNA is not influenced by AGG interruptions.

Authors:  Anna L Ludwig; Christopher Raske; Flora Tassone; Dolores Garcia-Arocena; John W Hershey; Paul J Hagerman
Journal:  Nucleic Acids Res       Date:  2009-09-14       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.